Citation Impact
Citing Papers
Cluster failure: Why fMRI inferences for spatial extent have inflated false-positive rates
2016 Standout
The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
2001
The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study
2010 Standout
More insight into the fate of biomedical meeting abstracts: a systematic review
2003
Estimating the reproducibility of psychological science
2015 StandoutScience
Improving the reporting of pragmatic trials: an extension of the CONSORT statement
2008
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
No health without mental health
2007 Standout
Interventions to Improve Medication Adherence in Schizophrenia
2002
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Treatment and prevention of mental disorders in low-income and middle-income countries
2007
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS
2002
Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis
2011
Systematic Reviews: Identifying relevant studies for systematic reviews
1994 Standout
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
2001 Standout
Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups
2007 Standout
Why Most Published Research Findings Are False
2005 Standout
Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
2006
Reports of Large Immunosuppression Trials in Kidney Transplantation: Room for Improvement
2004
Association of Industry Sponsorship to Published Outcomes in Gastrointestinal Clinical Research
2006
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: A re-examination
2003
Standardising outcomes for clinical trials and systematic reviews
2007
Rivers in Practice: Clinicians' Assessments of Patients' Decision-Making Capacity
1989
Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache
1999 Standout
WHO World Mental Health Surveys International College Student Project: Prevalence and distribution of mental disorders.
2018 Standout
Presentation in relation to publication of results from clinical trials
2006
Factors That Can Affect the External Validity of Randomised Controlled Trials
2006
Elaboración de directrices para la publicación de investigación biomédica: proceso y fundamento científico
2005
Scientific method: Statistical errors
2014 StandoutNature
Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention
2000
Causes of deaths in children younger than 5 years in China in 2008
2010
A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia
2003
Short-term symptomatic and functional outcomes of schizophrenia in Butajira, Ethiopia
2005
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
2013 Standout
Dropout rates in randomised antipsychotic drug trials
2001
Mental health literacy
2000 Standout
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
Evaluation of the methodological quality of systematic reviews of health status measurement instruments
2009
Rethinking schizophrenia
2010 StandoutNature
Assessment of Patients' Competence to Consent to Treatment
2007 Standout
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000
2012 Standout
Meta-analyses involving cross-over trials: methodological issues
2002 Standout
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
2007 Standout
Funding source, trial outcome and reporting quality: are they related? Results of a pilot study
2002
How Well Are Randomized Controlled Trials Reported in the Dermatology Literature?
2000
Alzheimer's disease
2016 Standout
Direction and impact of language bias in meta-analyses of controlled trials: empirical study
2002
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Publication Bias of Randomized Controlled Trials in Emergency Medicine
2005
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study
2011
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis
2013 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data
2013 Standout
Risperidone versus placebo for schizophrenia
2008
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Identification and impact of outcome selection bias in meta‐analysis
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Adherence to Medication
2005 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Psychoeducation for schizophrenia
2011
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
2004
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students
2016 Standout
The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say?
2007
Systems to rate the strength of scientific evidence.
2002
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
2001 Standout
Psychosocial interventions for conversion disorder
2005
Full publication of results initially presented in abstracts
2007 Standout
Risperidone versus other atypical antipsychotics for schizophrenia
2011
Bias in Meta-Analysis Due to Outcome Variable Selection Within Studies
2000
Why Most Published Research Findings Are False
2005 Standout
Randomisation to protect against selection bias in healthcare trials
2011
Systematic reviews of trials and other studies.
1998
Acamprosate for alcohol dependence
2010
Publication and related biases.
2000
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Some Practical Guidelines for Effective Sample Size Determination
2001
Risperidone versus placebo for schizophrenia
2016
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Evaluating replicability of laboratory experiments in economics
2016 StandoutScience
Industry sponsorship and research outcome
2017 Standout
Outcome selection bias in meta-analysis
2005
Promoting Transparency in Social Science Research
2014 StandoutScienceNobel
Works of Clive E Adams being referenced
Haloperidol dose for the acute phase of schizophrenia
2002
A systematic review of studies of depression prevalence in university students
2012
A systematic approach to evaluation of care: The Cochrane Collaboration
1995
Systematic meta-review of depot antipsychotic drugs for people with schizophrenia
2001
Chlorpromazine versus placebo for schizophrenia
2007
Psycho-education with problem solving (PEPS) therapy for adults with personality disorder: A pragmatic multi-site community-based randomised clinical trial
2011
Abstracts of trials presented at the Vth World Congress of Psychiatry (Mexico, 1971): a cohort study
1999
Evidence of Clozapine’s Effectiveness in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Trials
1999
Five large Chinese biomedical bibliographic databases: accessibility and coverage
2008
A Comparison of Clinical and Judicial Procedures for Reviewing Requests for Involuntary Medication in New York
1988
Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial
2007
Content and quality of 2000 controlled trials in schizophrenia over 50 years
1998
Searching the right database. A comparison of four databases for psychiatry journals
1999
An investigation of the adequacy of MEDLINE searches for randomized controlled trials (RCTs) of the effects of mental health care
1994
Influence of Methodology on Outcomes of Randomised Clozapine Trials
2000
Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia
2000
Randomized controlled trials in schizophrenia: a critical perspective on the literature
2002
Schizophrenia. Full National Clinical Guideline on Core Interventions in Primary and Secondary Care National Collaborating Centre for Mental Health London: Gaskell, 2003, £50 pb, including 2 CD-ROMs, 264 pp., ISBN: 1-901242-97-8, Book ID: 1747
2004
Chlorpromazine versus placebo for schizophrenia
2014
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)
2017
Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation)
2018
Supportive therapy for schizophrenia
2015
Haloperidol dose for the acute phase of schizophrenia
2013
Risperidone for psychosis induced aggression or agitation
2011
Haloperidol versus placebo for schizophrenia
2013
Losing participants before the trial ends erodes credibility of findings
2009